Brief: Apeiron Investment Group Ltd Reports 11.2% Stake In Sensei Biotherapeutics

Faeth Therapeutics,

19/07/2022 22:44

July 19 (Reuters) - Sensei Biotherapeutics Inc  SNSE.O :
    * APEIRON INVESTMENT GROUP LTD REPORTS 11.2% STAKE IN SENSEI
BIOTHERAPEUTICS AS OF JULY 14 - SEC FILING
    * APEIRON INVESTMENT GROUP - PURCHASED SENSEI
BIOTHERAPEUTICS
SHARES BASED ON BELIEF THAT SHARES, WHEN PURCHASED, REPRESENTED
ATTRACTIVE OPPORTUNITY
    * APEIRON INVESTMENT GROUP - SHARES OF SENSEI
BIOTHERAPEUTICS
CURRENTLY TRADE AT DISCOUNT TO ITS CASH/LIQUIDATION VALUE
    * APEIRON INVESTMENT GROUP -  INTENDS TO ENGAGE IN
DISCUSSIONS
WITH SENSEI BIOTHERAPEUTICS' BOARD AND MANAGEMENT


Further company coverage:  SNSE.O 

 ((Reuters.Briefs@thomsonreuters.com;))